STLN Starling Oncology, Inc.
Updated
Healthcare · Services-Offices & Clinics Of Doctors Of Medicine
Starling Oncology, Inc. (STLN) is a healthcare company in the Services-Offices & Clinics Of Doctors Of Medicine industry, with a market capitalization of $522 million. Shares last traded at $5.92, 15.8% below their 52-week high. Net profit margin is -6.2%, below the peer median of -5.8%. Revenue grew 27.8% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-0.10 | 2026-08-06 |
| Q1 2026 | $-0.02 | 2026-05-07 |
| FY 2025 | $-0.54 | 2026-03-12 |
| Q3 2025 | $-0.49 | 2025-11-13 |
| Q2 2026 | $-0.35 | 2026-08-06 |
| Q1 2026 | $-0.21 | 2026-05-07 |
Services-Offices & Clinics Of Doctors Of Medicine peers
STLN vs 10 industry peers (Services-Offices & Clinics Of Doctors Of Medicine), by market cap. Updated
| HIMS | Hims & Hers Health, Inc. | $6.4B | -45.03 | 2.48 | -5.5% | -3.27% |
| TDOC | Teladoc Health, Inc. | $1.2B | -6.64 | 0.47 | -7.1% | +0.39% |
| SBC | SBC Medical Group Holdings Inc | $439M | 8.96 | 2.51 | 28.0% | +1.18% |
| AIRS | Airsculpt Technologies, Inc. | $185M | -15.72 | 1.22 | -7.8% | +3.64% |
| LFMD | Lifemd, Inc. | $147M | 732.56 | 0.89 | 0.1% | -0.16% |
| CCM | Concord Medical Services Holdings Ltd | — | — | — | -20.2% | -5.11% |
| SBCWW | SBC Medical Group Holdings Inc | — | — | — | 28.0% | +5.82% |
| STLN | Starling Oncology, Inc. | — | — | — | -6.2% | -0.92% |
| AUNA | Auna S.A. | — | — | — | — | +2.57% |
| BMGL | Basel Medical Group Ltd | — | — | — | — | -5.69% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.